GRANTS

VIDEC (Visualizing Death Inducing Protein Complexes)

The Research network aims to develope tools for visualizing cell death to enhance treatments and identify chemical hazards.

ongoing
GRANTS

ZeNeuroid: Human-based Neural Organoid Network for Parkison Drug Discovery

The project takes advantage of patient-derived iPSCs and CRISPR-edited human iPSCs to create a Parkinson Disease neuronal disease model.

ongoing
GRANTS

ZeNeuroid: Human-based Neural Organoid Network for Drug Discovery

The project will use patient derived-iPSC and CRISPR-edited human IPSC to develop a novel three-dimensional microfluidic system for drug discovery.

ongoing
GRANTS

EdiGenT – New Prime Editing and non-viral delivery strategies for Gene Therapy

The EdiGenT consortium will work to develop a new generation of more efficient gene correction tools based on the CRISPR/Cas9 system, and non-viral delivery strategies for gene therapy.

ongoing
GRANTS

Kit Digital

Eleva Group has assisted ZeClinics in the installation of a Customer Relationship Management (CRM).

completed
GRANTS

ZeBYTE – Platform to predict the effect of drugs based on the use of zebrafish and artificial intelligence

ZeBYTE aims at using artificial intelligence technologies along the whole target discovery process.

completed
GRANTS

Nonalcoholic fatty liver disease (NAFLD): from pathophysiology to therapy

The goal of the project is to generate NAFLD zebrafish models – dietary and genetic – to allow the identification of new biomarkers of the disease and therapeutic targets

ongoing
GRANTS

REMODEL – pREcise gene delivery for advanced disease MODELing

A cutting-edge gene-editing platform to generate complex disease models to test innovative therapeutic approaches.

completed
GRANTS

ROBO-FISH – Automated high-throughput oncology drug screening in zebrafish using robotics and AI

The ROBO-FISH consortium will develop and validate injection and imaging robots to automate oncology drug screening in zebrafish to mimic human disease.

ongoing
GRANTS

CARDIOMYO – An integrated HTS platform for the discovery of new therapeutics against cardiomyopathies

CARDIOMYO combines three complementary approaches: 1) high content phenotypic in vitro cardiac assays 2) a novel in vivo cardiovascular phenotyping using zebrafish and 3) drug discovery chemistry

completed
GRANTS

NanoDIRE-CT – Use of nanobodies for targeted therapy against tumor stem cells

Our purpose is to isolate nanobodies that bind cancer stemm cells and have a direct cytotoxic effect on them, or could act as carriers of cytotoxic drugs specifically towards them.

ongoing
GRANTS

NanoDIRE-CT: Breakthroughs in the Last Year of ZeClinics and Vall d’Hebron Collaboration

completed
GRANTS

Search for new therapies against Parkinson’s disease using zebrafish

The aim of the project is to develop zebrafish models to understand Parkinson's disease and identify novel therapeutic targets and drugs

completed
GRANTS

Development of zebrafish models of GRINpathies, phenotyping and drug screening

The project aims to create and characterize genetic models of GRIN gene loss-of-function associated to GRD, a rare disease defined as a neurodevelopmental encephalopathy.

completed
GRANTS

SCilS – Studying Ciliary Signaling in Development and Disease

SCilS is training a new generation of scientists to characterise ciliopathies, an increasingly important and diverse class of inherited diseases.

completed
GRANTS

REANIMA – New-generation cardiac therapeutic strategies directed to the activation of endogenous regenerative mechanisms

REANIMA aims to deliver new therapies for heart regeneration, thereby reverting the conditions that lead to heart failure.

ongoing